Regenxbio RGNX Cash Flow Statement (2014-2026)

NASDAQ RGNX
$7.62 -0.45 (-5.58%)
As of: Nov 10, 2026 · 3:05 PM EST
Reported Financials

Regenxbio Quarterly Cash Flow Statement

Periods 48 quarters
Latest Jun 2026

Regenxbio reported cash from operations of -$62.24M and free cash flow of -$63.00M for the quarter ended Jun 2026, down 26.1% year over year. This cash flow statement covers 48 quarters of results from Sep 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-58.41M294.02M-76.72M-68.18M-75.48M-59.94M-66.68M-72.06M-61.87M-62.89M-63.33M-52.99M-59.60M-51.19M6.08M-70.87M-61.94M-67.15M22.69M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
2.83M2.64M2.59M2.64M3.55M4.13M4.18M4.44M4.37M4.34M4.18M4.05M3.96M4.02M3.96M3.91M3.89M3.87M3.86M3.76M
Share-based CompensationStock Comp.
9.73M9.16M10.80M10.34M10.25M9.41M11.21M10.50M10.22M8.34M9.60M9.44M9.88M9.54M8.54M8.65M9.00M8.38M9.05M
Gains from Investment SecuritiesGains Investment
5.18M-0.01M
Asset Writedowns and ImpairmentWritedown
2.10M
Other non-cash itemsOther Non-Cash
0.62M0.24M-0.08M1.02M0.11M-0.68M-0.70M-0.71M0.83M0.48M0.62M-0.72M0.45M7.07M-0.29M2.79M5.35M5.64M3.77M5.98M
Change in Working Capital
Change in ReceivablesChange Receivables
6.40M-22.00M-5.69M10.72M-5.01M-4.84M-9.50M2.39M6.54M-3.37M-9.18M6.89M0.71M-8.13M-1.57M2.36M6.31M0.56M-18.25M96.71M
Change in Account PayablesChange Payables
7.35M-8.81M16.76M-7.23M7.36M1.91M-3.10M-11.01M10.10M1.22M8.46M-14.92M3.12M3.04M-3.65M2.53M0.69M-1.86M0.35M-5.29M
Change in Accrued ExpensesChange Accrued Exp.
6.35M29.44M-26.47M0.88M-2.65M2.63M-15.44M18.94M-5.05M4.00M-17.08M9.53M6.10M-10.68M-14.49M11.92M2.75M0.05M-16.73M1.17M
Change in Other Operating AssetsOther Assets Change
6.20M1.14M-2.13M-4.35M-1.36M-1.74M15.78M-7.09M-2.43M-2.45M3.78M-10.18M0.63M-13.19M1.62M0.26M2.87M-8.58M0.13M-3.21M
Change in Other Operating LiabilitiesOther Liabilities Change
0.33M0.62M7.94M3.86M-1.08M-4.32M-4.79M-2.51M-1.56M-1.81M-4.94M-1.93M-1.82M-2.03M34.60M-4.30M-4.64M-8.00M-3.24M-5.66M
Other Working Capital ChangesOther WC Changes
-5.87M-0.53M10.07M8.21M0.27M-2.58M-20.56M4.57M0.87M0.64M-8.72M8.25M-2.45M11.16M32.98M-4.56M-7.51M0.58M-3.37M-2.45M
Cash from OperationsCash from Ops.
-42.50M341.50M-55.91M-61.75M-50.46M-39.37M-80.92M-47.32M-49.41M-40.76M-55.46M-45.50M-40.55M-31.62M33.63M-49.34M-55.96M-52.29M-76.19M-62.24M
Investing Activities
Capital ExpendituresCapex
18.70M14.61M10.97M9.24M5.05M5.47M4.82M2.58M1.44M1.13M0.56M0.47M0.33M1.08M1.02M0.39M0.49M0.51M1.24M0.76M
Change in Property, Plant and EquipmentChange in PP&E
-18.70M-14.61M-10.97M-9.24M-5.05M-5.47M-4.82M-2.58M-1.44M-1.13M-0.56M-0.47M-0.33M-1.08M-1.02M-0.39M-0.49M-0.51M-1.24M-0.76M
Purchase of InvestmentsInvestments Purchased
20.68M235.47M129.49M28.87M14.55M11.97M49.80M18.13M18.64M55.19M82.53M36.20M16.22M19.16M211.14M39.52M62.81M9.84M
Sale and Maturity of InvestmentsInvestments Sold
49.92M33.73M49.86M37.03M72.12M44.14M67.91M107.59M56.25M53.74M68.93M82.73M86.78M51.79M64.92M71.10M82.24M100.86M81.66M55.22M
Cash from Investing ActivitiesCash from Investing
16.10M-216.36M-90.59M-1.08M53.04M26.70M63.09M55.22M38.66M33.97M13.18M-0.27M50.26M40.27M44.74M-140.44M42.29M37.54M70.59M65.93M
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued
2.87M1.00M0.96M1.51M2.04M0.04M1.05M0.75M6.21M0.21M132.90M-0.06M0.89M0.04M0.46M0.08M0.74M0.09M0.79M19.55M
Net Shares Issued and RepurchasedNet Shares Issued
2.87M1.00M0.96M1.51M2.04M0.04M1.05M0.75M6.21M0.21M132.90M-0.06M0.89M0.04M0.46M0.08M0.74M0.09M0.79M19.55M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
2.87M1.00M0.96M1.51M2.04M0.04M1.05M0.75M6.21M0.21M132.90M-0.06M0.89M0.04M0.46M0.08M0.74M0.09M0.79M19.55M
Other financing activities (as filed)
-5.15M-8.60M-7.51M-9.18M-7.45M-8.96M-9.67M-9.91M-10.96M-11.75M-11.23M-9.53M-11.48M-7.61M-5.59M
Cash from Financing ActivitiesCash from Financing
-2.28M-7.62M-6.83M-7.67M-5.42M-8.92M-9.04M-9.16M-4.81M-11.96M120.73M-9.45M-10.86M-7.74M-5.79M139.23M-7.08M-9.58M-13.64M17.57M
Additional items
Change in Cash
-28.69M117.52M-153.34M-70.50M-2.83M-21.59M-26.86M-1.27M-15.56M-18.75M78.45M-55.21M-1.15M0.91M72.58M-50.55M-20.76M-24.34M-19.24M21.26M
Ending Cash Balance
229.72M347.24M193.90M123.40M120.57M98.98M72.12M70.86M55.30M36.55M115.01M59.80M58.65M59.56M132.13M81.59M60.83M36.50M38.52M
Free Cash FlowFCF
-61.20M326.88M-66.88M-70.99M-55.51M-44.84M-85.74M-49.90M-50.85M-41.89M-56.01M-45.97M-40.88M-32.70M32.61M-49.73M-56.45M-52.80M-77.42M-63.00M
Net Cash FlowNCF
-28.69M117.52M-153.34M-70.50M-2.83M-21.59M-26.86M-1.27M-15.56M-18.75M78.45M-55.21M-1.15M0.91M72.58M-50.55M-20.76M-24.34M-19.24M21.26M
Interest Paid

Regenxbio Cash Flow Statement API

Pull Regenxbio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RGNX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY